Protein-loaded poly(epsilon-caprolactone) microparticles. II. Muramyl dipeptide for oral controlled release of adjuvant

References

• C HAN, T. W., and B ECKER, A., 1988, Formulation of vaccine adjuvant muramyldipeptides (MDP). 1. Characterization of amorphous and crystalline forms of a muramyldipeptide analogue. Pharmaceutical Research, 5, 523–527.
   PubMedGoogle Scholar
• CHEDID, L., A UDIBERT, F., L EFRANCIER, P. CHOAY, J., and L EDERER, E., 1976, Modulation of the immune response by a synthetic adjuvant and analogues. Proceedings of the National Academy of Sciences (USA), 73, 2472–2475.
   Google Scholar
• CRESCENZI, V., MANZIM, G., C ALZOLAVI, G., and B ORRI, C., 1972, Thermodynamics of fusion of poly-beta-propiolactone and poly(e-caprolactone). Comparative analysis of the melting of aliphatic polylactone and polyesters chains. European Polymer Journal, 8, 449–463.
   Google Scholar
• E LDRIDGE, J. H., H AMMOND, C. J., M EULBROEK, J. A., S TAAS, J. K., G ILLEY, R. M., and T ICE, T. R., 1990, Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. Journal of Controlled Release, 11, 205–214.
   Google Scholar
• E LLOUZ, F., ADAM A., C IORBARu, R., and L EDERER, E, 1974, Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochemical and Biophysical Research Communications, 59, 1317–1325.
   Google Scholar
• F IDLER, I. J., FAN, D., and I0-11NOSE, Y., 1988, Potent in-situ activation of murine lung macrophages and therapy of melanoma metastases by the systemic administration of muramyltripeptide phosphatidylethanoamine and interferon gamma. Invasion Metastases, 9, 95–98.
   Google Scholar
• FIDLER, I. J., SONE, S., F OGLER, W. E., and BARNES, Z. L., 1981, Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proceedings of the National Academy of Sciences (USA), 78, 1680–1684.
   PubMedGoogle Scholar
• HALLS, T. D. J., R AJU, M. S., W ENKERT, E., Z UBER, M., L EFRANCIER, 0., and L EDERER, E., 1980, The anomeric configuration of the immunostimulant N-acetylmuramyl-dipeptide and some of its derivatives. Carbohydrate Research, 81, 173–176.
   Google Scholar
• H ORA, M. S., RANA, R. K., NuNBERG, J. H., TICE, T. R., G ILLEY, R. M., and HUDSON, M. E., 1990, Release of human serum albumin from poly(lactide-co-glycolide) micro-spheres. Pharmaceutical Research, 7, 1190–1194.
   PubMedGoogle Scholar
• LIDGATE, D. M., and BYERS, N. E., 1995, Development of an emulsion-based muramyl dipeptide adjuvant formulation for vaccines. In Vaccines Design: The subunit and adjuvant approach, edited by M. F. Powell and M. J. Newman (New York: Plenum Press), pp. 313–324.
   Google Scholar
• LOWRY, 0. M., ROSEBROUGH, N. J., FARR, A. L., and RANDALL, R. J., 1951, Protein measurement with Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• MARX, P. A., COMPANS, R. W., GETTIE, A., STAAS, J. K., GILLEY, R. M., MULLIGAN, M. J., YAMSHCHIKOV, G. V., CHEN, D., and ELDIUDGE, J., 1993, Protection against vaginal STY transmission with microencapsulated vaccine. Science, 28, 1323–1327.
   Google Scholar
• MORIN, C., BARRATT, G., FESSI, H., DEVISSAGUET, J. P., and PUISIEUX, F., 1993, Biodegradable nanocapsules containing a lipophilic immunomodulator: drug retention and tolerance towards macrophages in vitro. Journal of Drug Targeting, 1, 157–164.
   PubMedGoogle Scholar
• PARANr, M., PARANT, F., CHEDID, L., YAPQ A., PETIT, J. F., and LEDERER, E., 1979, Fate of the synthetic immunoadjuvant muramyldipeptide (14C-labelled) in the mouse. International Journal of Immunopharmacology, 1, 35–41.
   Google Scholar
• PITT. C. G., 1990, Poly(e-caprolactone) and its copolymers. In Biodegradable polymers as drug delivery systems, edited by M. Chasin and R. Langer (New York: Marcel Dekker), pp. 71–120.
   Google Scholar
• POWELL M. F., FOSTER, K. C., BECKER, A. R., and LEE, 1988, Formulation of vaccine adjuvant muramyldipeptides (MDP). 2. The thermal reactivity and pH of maximum stability of MDP compounds in aqueous solution. Pharmaceutical Research, 5, 528–532.
   Google Scholar
• SPONTON, E., DROUIN, D., DELATTRE, J., PUISIEUX, F., TENU, J. P., YAPQ A., BARRATT, G., and PETIT, J. F., 1985, Design of sterile muramyldipeptide-containing oligolamellar liposomes suitable for iv. injection. Effect of liposome size and lipid composition on their ability to render peritoneal macrophages antitumoral. International Journal of Pharmaceutics, 23, 299–313.
   Google Scholar
• T ABATA, Y., and IICADA, Y, 1987a, Activation of macrophage in vivo to acquire antitumor activity by a muramyl dipeptide derivative encapsulated in microspheres composed of lactide copolymer. Journal of Controlled Release, 6, 189–204.
   Google Scholar
• T ABATA, Y., and IKADA, Y., 1987b, Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheres. Journal of Pharmacy and Pharmacology, 39, 698–704.
   PubMedGoogle Scholar
• T ABATA, Y., and IICADA, Y., 1989, Protein precoating of polylactide microspheres containing a lipophilic immunopotentiator for enhancement of macrophage phagocytosis and activation. Pharmaceutical Research, 6, 296–301.
   PubMedGoogle Scholar
• VOGEL, F. R., 1995, The role of adjuvants in retroviral vaccines. International Journal of Immunopharmacology, 17, 85–90.
   PubMedGoogle Scholar
• YANG, D., PEYmAN, G. A., and TANG, L., 1996, Chemical modification of PCL and the effect on drug release rate. Proceedings CRS Conference on Advances in Controlled Delivery, Baltimore, 19–22 August, pp. 47–48.
   Google Scholar
• YOuAN, B. B. C., BENOIT, M. A., BARAS, B., and GILLARD, J., 1996, Characterization and in vitro release of polycaprolactone microparticles containing bovine serum albumin. Journal de Phamacie de Belgique, 51, 123.
   Google Scholar
• YOUAN, B. B. C., BENOIT, M.-A., BARAS, B., and GILLARD, J., 1999, Protein-loaded poly(e-caprolactone) microparticles I. Optimization of the encapsulation by (water-in oil)-in water emulsion solvent evaporation. Journal of Microencapsulation, in press.
   Google Scholar